• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Oncology

Adherence to pre-treatment imaging guidelines for staging in rectal cancer is increasing, but a gap still remains

byKassandra McFarlaneandSamuel Chan
April 4, 2022
in Gastroenterology, Oncology, Surgery
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Adherence to the guidelines increased from 38% to 56% between Fall 2016 and 2019; and from 37% to 70% between Spring 2017 and 2019.

2. Confusion over which practitioner is responsible for obtaining imaging is one of the reasons for reduced adherence to the recommendations.

Evidence Rating Level: 3 (Average)

Study Rundown: Current guidelines for the management of rectal cancer recommend pre-treatment staging via pelvic magnetic resonance imaging (MRI) or endorectal ultrasound. This study aimed to determine whether providers were performing initial staging imaging for rectal cancer prior to surgery or starting therapy, and if not, the reasons for that. While adherence to the guideline-recommendations increased from 38% to 56% between Fall 2016 and Fall 2019 and from 37% to 70% between Spring 2017 and Spring 2019, survey feedback indicated ongoing confusion amongst practices concerning which practitioner should order the scans. Limited awareness regarding appropriate scans was also provided as a reason for the discordance with the recommendations. Limitations to this study include the small sample size and the integrity of the data due to self-reported survey responses by the practices. Overall, it was found that adherence to the recommendations was increasing over time, however, a focus on quality improvement is needed as up to 50% of patients are still not receiving imaging prior to treatment.

Click to read the study in The Journal of Clinical Oncology

Relevant Reading: Neoadjuvant radiotherapy for rectal cancer management

In-Depth [survey]: This quality improvement study performed in the United States explored the adherence to the guideline recommendations for imaging in rectal cancer pre-treatment staging. Seven different time points were examined for appropriate initial rectal cancer staging between 2016 and 2019 and between 20 and 33 practices responded at each time point. The data for 1,158 unique patients was included. Adherence was shown to be increasing: in Fall 2016, 38% of patients were provided initial staging as per the guidelines (95% confidence interval (CI), 28-48%), compared to 56% in Fall 2019 (95% CI, 45-67%). In Spring of 2017, 37% of patients received guideline-recommended staging (95% CI, 28-46%) compared to 70% in Spring 2019 (95% CI, 61-78%). Nonconcordance was attributed by practices primarily due to an absence of coordination between providers such as the surgery and oncology providers (16 of 28 practices, or 57.1%). Another contributing factor was limited awareness of appropriate scans for initial staging (8 of 28 practices, or 28.6%).

RELATED REPORTS

#VisualAbstract: Stage-specific and time-specific recurrence data can help determine need for surveillance in Merkel cell carcinoma patients

Capecitabine + oxaliplatin chemoradiotherapy does not increase survival, but increases toxicity, compared to capecitabine alone in the postoperative treatment of rectal cancer

#VisualAbstract: 18-F fluorodeoxyglucose positron emission tomography offers a high negative predictive value for detection of cervical lymph node metastases

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cancer stagingquality improvement (QI)rectal cancer
Previous Post

Carotuximab addition to pazopanib does not improve survival in advanced angiosarcoma patients

Next Post

Barriers to medication access for opioid use disorder in adolescents and young adults

RelatedReports

#VisualAbstract: Stage-specific and time-specific recurrence data can help determine need for surveillance in Merkel cell carcinoma patients
StudyGraphics

#VisualAbstract: Stage-specific and time-specific recurrence data can help determine need for surveillance in Merkel cell carcinoma patients

March 11, 2022
Genetic, environmental risk assessment does not increase colon cancer screening
Chronic Disease

Capecitabine + oxaliplatin chemoradiotherapy does not increase survival, but increases toxicity, compared to capecitabine alone in the postoperative treatment of rectal cancer

December 3, 2021
#VisualAbstract: 18-F fluorodeoxyglucose positron emission tomography offers a high negative predictive value for detection of cervical lymph node metastases
StudyGraphics

#VisualAbstract: 18-F fluorodeoxyglucose positron emission tomography offers a high negative predictive value for detection of cervical lymph node metastases

August 5, 2021
Benefits of high-intensity surveillance following colorectal adenoma removal likely outweigh costs
Chronic Disease

Neoadjuvant pembrolizumab with chemoradiotherapy not supported for locally advanced rectal cancer after chemotherapy treatment

July 6, 2021
Next Post
Quick Take: The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomized trial

Barriers to medication access for opioid use disorder in adolescents and young adults

Patient Basics: Nosebleed (Epistaxis)

Induction chemotherapy with paclitaxel, cisplatin and capecitabine showed promising clinical and safety response to treat advanced nasopharyngeal carcinoma

Steep decline in post-operative opioid prescriptions for common pediatric surgeries

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Bimekizumab shows a favourable 2-year safety profile in patients with moderate to severe plaque psoriasis
  • Medical cannabis provides little improvement to sleep in chronic pain patients
  • Alzheimer disease in individuals with Down syndrome has similar variability in age of onset and mortality rate as autosomal dominant forms
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.